文献速递神经肿瘤

弥漫性低级别胶质瘤的分子特征:神经外科医生需要了解的内容

Molecular characteristics of diffuse lower grade gliomas: what neurosurgeons need to know.
PubMed 文献 · Acta Neurochir (Wien) · 2020-05-30

本文综述WHO 2016分类将基因型与表型结合用于胶质瘤诊断的意义,强调遗传标志物可降低组织采样误差风险、提高诊断准确性并减少评估者间差异。神经外科医生需理解遗传学在肿瘤生物学、预后及辅助治疗中的作用,并学会解读肿瘤切除后测序数据。

要点

  • WHO 2016分类结合表型和基因型诊断胶质瘤,减少采样误差。
  • 遗传标志物有助于判断预后和指导辅助治疗。
  • 神经外科医生需能解读肿瘤切除后的测序结果。

核心结论

  • 遗传学在弥漫性低级别胶质瘤诊断和预后中起关键作用,神经外科医生应掌握相关分子知识。

研究设计与样本

  • 综述,阐述WHO 2016分类中基因型与表型结合诊断胶质瘤的意义及对神经外科医生的要求。

主要发现

  • 使用遗传标志物分类肿瘤并指导预后,可降低组织采样误差风险、提高诊断准确性并减少评估者间差异。

临床怎么用

  • 神经外科医生应理解遗传学在肿瘤生物学中的作用、特定突变对预后和辅助治疗的意义,并能解读切除后测序数据。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The importance of genomic information in intrinsic brain tumors is highlighted in the World Health Organization (WHO) 2016 classification of gliomas, which now incorporates both phenotype and genotype data to assign a diagnosis. By using genetic markers to both categorize tumors and advise patients on prognosis, this classification system has minimized the risk of tissue sampling error, improved diagnostic accuracy, and reduced inter-rater variability. In the neurosurgical community, it is critical to understand the role genetics plays in tumor biology, what certain mutations mean for the patient's prognosis and adjuvant treatment, and how to interpret the results of sequencing data that are generated following tumor resection. In this review, we examine the critical role of genetics for diagnosis and prognosis and highlight the importance of tumor genetics for neurosurgeons caring for patients with diffuse lower grade gliomas.

来源:Acta Neurochir (Wien),查看原文。版权归原作者所有。

引用

  1. Young JS, Gogos AJ, Morshed RA, et al. Molecular characteristics of diffuse lower grade gliomas: what neurosurgeons need to know. Acta Neurochir (Wien). 2020. PMID: 32472378. doi:10.1007/s00701-020-04426-2

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。